Delivery Order SPE2DB24D2217-SPE2DB25FJWTS

Award Date 4/16/25
Potential Completion Date 4/17/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,659.80, is a delivery order for 4,566,868,234 units of the medication Propranolol 20 mg tablets. The contract has an ultimate completion date of January 9, 2025 and is a firm fixed-price contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,789.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,223,409 units of 20 mg Propranolol tablets, a medication used to treat various cardiovascular conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order valued at $5,885.62 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,244,094 units of the drug Propranolol 20 mg tablet. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.46 firm-fixed-price delivery order is for the supply of 4,568,143,760 units of the prescription medication Propranolol 20 mg tablets. The contract has a period of performance through May 6, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This federal contract award, valued at $5,430.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,132,473 units of the medication Propranolol ER 120 mg capsules in 100-count packaging. The contract has a firm fixed-price pricing type and an ultimate completion date of May 6, 2025. Additionally, Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $1,376.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,985,059 units of the medication Propranolol ER 120 mg capsules. The contract is a firm fixed-price delivery order with an ultimate completion date of April 22, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. This award is...
This federal contract award (SPE2DB25D3005/SPE2DB25FQCQT) was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of the drug Propranolol 20 mg tablets. The $1,052.46 firm fixed-price contract has a completion date of February 20, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,266.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for 4,568,201,829 units of the medication Propranolol ER 120 mg capsules, with a performance period ending on May 12, 2025. The contract is not a set-aside, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Propranolol 10 mg tablets. The $2,009.70 firm fixed-price contract has an ultimate completion date of April 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $4,319.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,241,537 units of Propranolol ER 120 mg capsules. This contract is not set aside and is a firm fixed-price arrangement. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB24D2217
    Indefinite Delivery Contract
  • SPE2DB24D2217-SPE2DB25FJWTS
    Delivery Order

This federal contract award, valued at $1,004.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,941 units of the medication Propranolol 20 mg tablet. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 17, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

The contract award does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor and healthcare solutions provider, Amerisourcebergen Drug Corp is a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/16/25, 11:49 AM